Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

57.10 -0.40 (-0.70%)
Streaming Delayed Price Updated: 11:56 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. ↗
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. 
Via Chartmill
News headline image
Earnings Scheduled For February 8, 2024 ↗
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
News headline image
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗
Intuitive Surgical stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an increase from 74 to 85. 
Via Investor's Business Daily
News headline image
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise ↗
Intuitive Surgical stock got an IBD rating upgrade Monday. It edged up 0.37% to 274.16, its second day in a row of rising share price. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing? ↗
Why the quality investor may take a look at HAEMONETICS CORP/MASS (NYSE:HAE). 
Via Chartmill
News headline image
Exploring NYSE:HAE's quality characteristics. ↗
Should you consider HAEMONETICS CORP/MASS (NYSE:HAE) for quality investing? 
Via Chartmill
News headline image
Should you consider NYSE:HAE for quality investing? ↗
HAEMONETICS CORP/MASS (NYSE:HAE) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
News headline image
4 Analysts Have This to Say About Haemonetics ↗
 
Via Benzinga
News headline image
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade ↗
Intuitive Surgical stock dipped to an intraday low 180.07 in October last year as the bear market ended, then shot up to 358.07 on July 19. 
Via Investor's Business Daily
News headline image
Haemonetics Earnings Preview ↗
 
Via Benzinga
Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
Via Investor Brand Network
News headline image
Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits ↗
 
Via Benzinga
News headline image
Recap: Haemonetics Q4 Earnings ↗
 
Via Benzinga
News headline image
Looking Into Haemonetics's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market... 
Via Benzinga
News headline image
Earnings Preview: Haemonetics ↗
 
Via Benzinga
Where Haemonetics Stands With Analysts ↗
 
Via Benzinga
9 Analysts Have This to Say About Haemonetics ↗
 
Via Benzinga
News headline image
Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone ↗
Haemonetics stock rose within a buy zone on Tuesday, but Incyte stock toppled. 
Via Investor's Business Daily
News headline image
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 
Via MarketBeat
News headline image
InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold ↗
The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78. 
Via Investor's Business Daily
News headline image
Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst ↗
 
Via Benzinga
News headline image
Haemonetics: Q2 Earnings Insights ↗
Haemonetics (NYSE:HAE) reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Haemonetics beat estimated earnings... 
Via Benzinga
News headline image
Expert Ratings for Haemonetics ↗
Over the past 3 months, 6 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's session, 108 stocks hit new 52-week highs. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year ↗
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
News headline image
Cutera Stock Earns Relative Strength Rating Upgrade ↗
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
Via Investor's Business Daily
News headline image
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.